These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9052640)

  • 1. Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping.
    Oestreicher JH; Liu E; Berkowitz M
    Ophthalmology; 1997 Feb; 104(2):324-9. PubMed ID: 9052640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
    Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
    Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants.
    Arat YO; Shetlar DJ; Boniuk M
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):189-93. PubMed ID: 12918552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mersilene mesh versus sclera in wrapping hydroxyapatite orbital implants.
    Kassaee A; Kashkouli MB; Panjtanpanah M; Sadeghi A; Tabatabaee Z
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):41-4. PubMed ID: 16418664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vicryl-mesh wrap for the implantation of hydroxyapatite orbital implants: an animal model.
    Jordan DR; Ells A; Brownstein S; Munro SM; Grahovac SZ; Raymond F; Gilberg SM; Allen LH
    Can J Ophthalmol; 1995 Aug; 30(5):241-6. PubMed ID: 8529157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Vicryl mesh (polyglactin 910) for implantation of hydroxyapatite orbital implants.
    Jordan DR; Allen LH; Ells A; Gilberg S; Brownstein S; Munro S; Grahovac S; Raymond F
    Ophthalmic Plast Reconstr Surg; 1995 Jun; 11(2):95-9. PubMed ID: 7654624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of autogenous sclera as wrapping material in hydroxyapatite implantation.
    Yoon JS; Lew H; Kook KH; Lee SY
    Ophthalmologica; 2009; 223(1):7-11. PubMed ID: 18849630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of vicryl mesh in 200 porous orbital implants: a technique with few exposures.
    Jordan DR; Klapper SR; Gilberg SM
    Ophthalmic Plast Reconstr Surg; 2003 Jan; 19(1):53-61. PubMed ID: 12544793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of motility peg placement for the hydroxyapatite orbital implant.
    Edelstein C; Shields CL; De Potter P; Shields JA
    Ophthalmology; 1997 Oct; 104(10):1616-21. PubMed ID: 9331200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of mersilene mesh for wrapping of hydroxyapatite orbital implants: mid-term result.
    Owji N; Mosallaei M; Taylor J
    Orbit; 2012 Jun; 31(3):155-8. PubMed ID: 22551365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients.
    Tabatabaee Z; Mazloumi M; Rajabi MT; Khalilzadeh O; Kassaee A; Moghimi S; Eftekhar H; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):114-8. PubMed ID: 20829725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma.
    Heimann H; Bechrakis NE; Zepeda LC; Coupland SE; Hellmich M; Foerster MH
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):123-8. PubMed ID: 15778666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of porous spherical orbital implants.
    Remulla HD; Rubin PA; Shore JW; Sutula FC; Townsend DJ; Woog JJ; Jahrling KV
    Ophthalmology; 1995 Apr; 102(4):586-93. PubMed ID: 7536909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyapatite orbital implants. Experience with 100 cases.
    McNab A
    Aust N Z J Ophthalmol; 1995 May; 23(2):117-23. PubMed ID: 7546686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polytetrafluoroethylene as a wrapping material for a hydroxyapatite orbital implant.
    Kao LY
    Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):286-8. PubMed ID: 10923976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term follow up of bone derived hydroxyapatite orbital implants.
    Suter AJ; Molteno AC; Bevin TH; Fulton JD; Herbison P
    Br J Ophthalmol; 2002 Nov; 86(11):1287-92. PubMed ID: 12386091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of exposure of porous orbital implants following enucleation.
    Wang JK; Liao SL; Lai PC; Lin LL
    Am J Ophthalmol; 2007 Jan; 143(1):61-67. PubMed ID: 17109809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
    Shah SU; Shields CL; Lally SE; Shields JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.